2 results
Approved WMORecruiting
To evaluate the potential effect of PPI administration in women with confirmed preeclampsia on sFlt-1 levels until delivery.
Approved WMORecruiting
The hypothesis is that the amivantamab and lazertinib combination (Arm A) will demonstrate superior PFS compared with single-agent osimertinib (Arm B).